Quick Order Cart

Cat. No. ARG0865

IL1RAP Knockout U-937 Cell Line

  • Product Type:

    Genome-edited Cells

  • Tissue Source:

    Pleural effusion

  • Disease:

    Acute monoblastic leukemia

  • Gene Species:

    Homo sapiens (Human)

The IL1RAP Knockout U-937 Cell Line is a CRISPR/Cas9-edited human monocytic cell line in which disruption of the interleukin-1 receptor accessory protein gene abolishes IL-1R1- and ST2 (IL1RL1)-mediated signaling. Loss of IL1RAP prevents ligand-induced recruitment of MYD88 and activation of NF-??B and MAPK cascades, leading to abrogated pro-inflammatory cytokine production. Derived from the U-937 histiocytic lymphoma line, this suspension cell model enables functional dissection of the IL-1/IL-33 axis in monocyte/macrophage biology, inflammatory disease research, and therapeutic validation for hematological malignancies and autoinflammatory conditions. Typical readouts include cytokine ELISA, phospho-NF-??B western blotting, and NF-??B luciferase reporter assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    U-937

    Age

    37 years

    Sex of Donor

    Male

    Gene Name

    Il1rap

    Gene Species

    Homo sapiens (Human)

    Gene Identifier

    NCBI Gene ID 3556

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

    Pathogens

    Cells tested negative for HIV-1, HBV, and HCV.

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The IL1RAP Knockout U-937 Cell Line is a CRISPR/Cas9-edited human knockout cell line in which IL1RAP gene disruption eliminates expression of the interleukin-1 receptor accessory protein. Derived from the parental U-937 line, this suspension cell model provides stable loss of IL1RAP function, preventing assembly of IL-1R1/IL1RAP and ST2/IL1RAP complexes and abrogating downstream signaling. U-937 is a human monocyte-like histiocytic lymphoma cell line originally isolated from a pleural effusion. It serves as a widely used model for monocyte and macrophage biology, characterized by phagocytic activity, cytokine production, and phorbol ester-induced differentiation. This suspension cell line enables versatile in vitro studies of immune signaling, inflammation, and hematopoietic malignancy. IL1RAP functions as an obligate coreceptor that pairs with IL-1R1 or ST2 (IL1RL1) to mediate signaling by IL-1??, IL-1??, and IL-33. Ligand binding recruits MYD88, IRAK4, IRAK1, and TRAF6, forming the Myddosome complex. IRAK1 and TRAF6 subsequently activate the IKK complex (IKBKB, CHUK, IKBKG)?CNF-??B axis and the p38 MAPK (MAPK14)?CJNK (MAPK8) cascades. Downstream, NF-??B and MAPK pathways drive transcription of pro-inflammatory genes such as IL6, TNFA, IL8, and CXCL8. TOLLIP modulates Myddosome dynamics. CRISPR/Cas9-mediated knockout of IL1RAP prohibits ligand-induced recruitment of MYD88 and phosphorylation of IRAK1/4, thereby halting NF-??B and MAPK activation and subsequent cytokine/chemokine production. In the U-937 monocytic background, IL1RAP knockout enables dissection of IL-1/IL-33 signaling roles in inflammatory responses and leukemic processes. The model is valuable for investigating pathological mechanisms in acute and chronic myeloid leukemias, myelodysplastic syndromes, autoinflammatory disorders, and rheumatoid arthritis. It also supports IL1RAP target validation and screening of antagonists, and studies of monocyte functions such as phagocytosis and differentiation within tumor microenvironments. Researchers can employ this line in functional assays including cytokine ELISA (IL-6, TNF-??), phospho-NF-??B western blotting, NF-??B reporter assays, and RT-qPCR for inflammatory genes. Flow cytometry and viability/apoptosis assays permit exploration of IL1RAP??s role in cell survival. Co-culture systems can assess monocytic contributions to tumor immunity. For further details, please contact Ascent Research.
Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)